A crack that formed by chance in an overheated chemical tank in Southern California relieved pressure and helped avert a catastrophic explosion, but officials said Tuesday it still wasn’t safe enough for 16,000 people living closest to the aerospace plant to return home. The crisis forced 50,000 people to evacuate in and around the Orange County city ...
The Trump administration has fired the two leaders of an influential health group that determines when insurance must provide free preventive care, like mammograms and colonoscopies, for millions of Americans. In letters dated May 11, Health Secretary Robert F. Kennedy Jr. notified the two doctors who chaired the U.S. Preventive Services Task Force that he was terminating ...
The Trump administration has proposed a “sweeping crackdown” on Medicaid payments that implements, and goes beyond, the reductions directed by last year’s sweeping One Big Beautiful Bill Act. Under a proposed rule, the Centers for Medicare & Medicaid Services takes aim at state-directed payments, aiming to bring Medicaid payments more in line with Medicare. The ...
The Trump administration recently finalized a major regulation governing the Affordable Care Act’s marketplaces, and community health plans are raising concerns about the impact the changes could have on consumers. Heather Foster, vice president for marketplace policy at the Association for Community Affiliated Plans (ACAP), told Fierce Healthcare in an interview that one of the biggest challenges ...
Employer benefits are often an important deciding factor for employees considering a job offer. Employers who review their benefits can attract qualified employees, especially with today’s focus on financial wellness. Although health insurance and retirement plans remain valuable, employers who add less common benefits to their packages can rise to the top of strong candidates’ ...
GLP-1 drugs are a double-edged sword for the nation’s employers. Although they are having a demonstrable effect on workplace health, the high cost is putting a strain on their budgets. GLP-1s, known by brand names such as Ozempic, Wegovy, Mounjaro or Zepbound, originally were developed to help regulate blood sugar in people with Type 2 ...